Anne Olson - Jan 1, 2022 Form 4 Insider Report for CENTERSPACE (CSR)

Role: COO, Gen Counsel and Secretary
Signature: Anne Olson
Stock symbol: CSR
Transactions as of: Jan 1, 2022
Transactions value $: $800,033
Form type: 4
Date filed: 1/4/2022, 05:00 PM
Previous filing: May 28, 2021
Next filing: Jan 31, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSR	Common Shares of Beneficial Interest	Options Exercise	$0	+539	+5.33%	$0.00	10.7K	Jan 1, 2022	Direct	F1
transaction	CSR	Common Shares of Beneficial Interest	Tax liability	-$34.5K	-311	-2.92%	$110.90	10.3K	Jan 1, 2022	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSR	Restricted Stock Units	Award	$0	+1.12K		$0.00	1.12K	Jan 1, 2022	Common Shares of Beneficial Interest	1.12K	$0.00	Direct	F3
transaction	CSR	Restricted Stock Units	Options Exercise	$0	-539	-33.29%	$0.00	1.08K	Jan 1, 2022	Common Shares of Beneficial Interest	539	$0.00	Direct
transaction	CSR	Stock Options (Right to Buy)	Award	$835K	+7.53K		$110.90	7.53K	Jan 1, 2022	Common Shares of Beneficial Interest	7.53K	$110.90	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The number of shares includes 929 additional shares that were not previously reported due to administrative errors. The majority of these shares are time-vested RSUs that were appropriately reported as derivates on the reporting person's Forms 4 at the time of grant, but not recategorized as shares of common stock at the time of vesting.
F2	Represents shares withheld for payment of taxes in connection with the vesting of restricted stock.
F3	Represents a contingent right to receive 1,121 common shares of beneficial interest of Centerspace vesting over three years, in one-third increments on each anniversary of the grant date: January 1, 2023, 2024 and 2025.
F4	Represents the right to purchase 7,525 common shares of beneficial interest of the Centerspace, vesting over four years in one-fourth increments on each anniversary of the grant date: January 1, 2023, 2024, 2025 and 2026.